Robert Langer

Dr. Langer serves as Scientific Advisor to PrognomiQ. He is one of 11 Institute Professors at the Massachusetts Institute of Technology. Dr. Langer’s scientific work, particularly in drug delivery systems and tissue engineering, has been cited over 328,000 times with an H-Index of 282 and his inventions include over 1400 issued or pending patents. He is the youngest person ever elected to all three U.S. National Academies (Science, Engineering, and Medicine). He is one of 3 living individuals to have won both the U.S. National Medal of Science (2006) and the U.S. National Medal of Technology and Innovation (2011); and he has won over 220 other major awards. He served as a member of the U.S. FDA’s Science Board from 1995-2002 and as its Chairman from 1999-2002. Dr. Langer has co-founded over 40 companies, including Moderna, Momenta, Seer, Frequency Therapeutics, Puretech, and Sigilon. Dr. Langer has a bachelor’s degree in chemical engineering from Cornell University and an Sc.D. in chemical engineering from MIT.